Skip to main content
logo
AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
295.95
+5.16 (1.77%)
Oct 30, 2026, 1:01 PM EDT - Market open

AbbVie Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
17,40416,99015,00216,61815,77615,42313,34315,10214,46014,46212,31014,30113,92713,86512,22515,12114,81214,58313,53814,886
Revenue Growth (YoY)
10.32%10.16%12.43%10.04%9.10%6.64%8.39%5.60%3.83%4.31%0.69%-5.42%-5.97%-4.92%-9.70%1.58%3.28%4.47%4.06%7.42%
Cost of Revenue
4,2854,2914,2184,5524,4574,3464,0024,2174,2074,2024,0634,1814,3654,2083,9724,1344,9984,1444,0213,080
Gross Profit
13,11912,69910,78412,06611,31911,0779,34110,88510,25310,2608,24710,1209,5629,6578,25310,9879,81410,4399,51711,806
Selling, General & Admin
4,0873,5533,4883,8193,4283,1833,2143,6864,0423,3143,0573,5553,2673,1532,9293,1043,1743,0942,8123,136
Research & Development
2,5672,3442,4722,5792,2912,1312,0672,2982,0721,9481,8131,9221,7221,7321,6621,7811,6101,6081,4881,812
Other Operating Expenses
-18-----24--7---169--169-10-1---68
Operating Expenses
6,6365,8975,9606,3985,7195,2905,2815,9776,1145,2624,8705,6464,9894,7164,5814,8844,7844,7024,3005,016
Operating Income
6,4836,8024,8245,6685,6005,7874,0604,9084,1394,9983,3774,4744,5734,9413,6726,1035,0305,7375,2176,790
Interest Expense
-700-746-717-714-739-740-700-702-720-726-660-564-555-552-553-566-560-556-548-580
Interest & Investment Income
-67725972627392129220207186157989990632499
Currency Exchange Gain (Loss)
-112-11-20-17-29-193-1-4-49-25-37-35-40-36-47-25-16
Other Non Operating Income (Expenses)
-738-55-312019985236317692875371242517425-8-15
EBT Excluding Unusual Items
5,0456,0694,1885,1225,1125,1773,4274,3423,7274,5832,9284,1224,1874,5743,1855,6384,5715,1834,6456,188
Merger & Restructuring Charges
-----95---282-161--34983-60-84-58-439-116-103-110-1,348
Gain (Loss) on Sale of Assets
-----------------172-68
Asset Writedown
-----847---4,476----1,500-2,100--630-106----
Legal Settlements
-----------485------2,200-200-
Other Unusual Items
--1,500-2,405-1,189-776-2,800-1,518-279-1,400-1,500-660-1,696-8-1,600-1,872-1,885-15-1,600739-232
Pretax Income
4,8294,2781,0392,6687141,5541,661-2,2692,0842,1461,7551,2121,9532,6104752,9654,4001,1834,9294,271
Income Tax Expense
609662342853526613372-2,246520773383388172583234493448255436226
Earnings From Continuing Operations
4,2203,6166971,8151889411,289-231,5641,3731,3728241,7812,0272412,4723,9529284,4934,045
Minority Interest in Earnings
-2-3-21-2-3-31-3-3-3-2-3-3-21-3-4-3-1
Net Income
4,2183,6136951,8161869381,286-221,5611,3701,3698221,7782,0242392,4733,9499244,4904,044
Preferred Dividends & Other Adjustments
-1281010101010101010111111111118111521
Net Income to Common
4,2183,6016871,8061769281,276-321,5511,3601,3598111,7672,0132282,4623,9319134,4754,023
Net Income Growth (YoY)
2296.59%288.04%-46.16%--88.65%-31.77%-6.11%--12.22%-32.44%496.05%-67.06%-55.05%120.48%-94.91%-38.80%24.48%21.57%26.55%20015.00%
Shares Outstanding (Basic)
1,7721,7691,7691,7741,7691,7681,7681,7691,7691,7681,7691,7721,7671,7671,7701,7781,7711,7701,7701,778
Shares Outstanding (Diluted)
1,7721,7711,7751,7741,7721,7711,7721,7691,7721,7711,7731,7721,7711,7711,7761,7781,7761,7761,7781,778
Shares Change (YoY)
--0.17%0.28%---0.06%-0.17%0.06%--0.17%-0.34%-0.28%-0.28%-0.11%--0.06%-0.11%0.11%
EPS (Basic)
2.382.040.391.020.100.520.72-0.020.880.770.770.461.001.140.131.382.220.522.532.26
EPS (Diluted)
2.372.030.391.020.100.520.72-0.020.880.770.770.461.001.140.131.382.210.512.522.26
EPS Growth (YoY)
2282.13%290.38%-46.06%--88.65%-32.40%-6.28%--12.32%-32.48%496.39%-66.95%-54.75%123.38%-94.89%-38.76%24.16%21.72%26.58%24889.89%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-3,1143,5644,8896,6434,8841,4006,7575,1982,0303,8474,5487,3556,1414,0187,2157,4254,8624,7464,888
Free Cash Flow Per Share
-1.762.012.763.752.760.793.822.931.152.172.574.153.472.264.064.182.742.672.75
Dividend Per Share
-1.7301.7301.7301.6401.6401.6401.6401.5501.5501.5501.5501.4801.4801.4801.4801.4101.4101.4101.410
Dividend Growth (YoY)
-5.49%5.49%5.49%5.81%5.81%5.81%5.81%4.73%4.73%4.73%4.73%4.96%4.96%4.96%4.96%8.46%8.46%8.46%8.46%
Gross Margin
75.38%74.74%71.88%72.61%71.75%71.82%70.01%72.08%70.91%70.95%66.99%70.76%68.66%69.65%67.51%72.66%66.26%71.58%70.30%79.31%
Operating Margin
37.25%40.03%32.16%34.11%35.50%37.52%30.43%32.50%28.62%34.56%27.43%31.29%32.84%35.64%30.04%40.36%33.96%39.34%38.54%45.61%
Profit Margin
24.24%21.20%4.58%10.87%1.12%6.02%9.56%-0.21%10.73%9.40%11.04%5.67%12.69%14.52%1.86%16.28%26.54%6.26%33.05%27.02%
Free Cash Flow Margin
-18.33%23.76%29.42%42.11%31.67%10.49%44.74%35.95%14.04%31.25%31.80%52.81%44.29%32.87%47.72%50.13%33.34%35.06%32.84%
EBITDA
8,3668,6856,7607,6557,6637,8376,0997,0106,2187,1295,4516,5506,8087,2015,7998,2607,2357,7897,2708,769
EBITDA Margin
48.07%51.12%45.06%46.06%48.57%50.81%45.71%46.42%43.00%49.30%44.28%45.80%48.88%51.94%47.44%54.63%48.85%53.41%53.70%58.91%
D&A For EBITDA
1,8831,8831,9361,9872,0632,0502,0392,1022,0792,1312,0742,0762,2352,2602,1272,1572,2052,0522,0531,979
EBIT
6,4836,8024,8245,6685,6005,7874,0604,9084,1394,9983,3774,4744,5734,9413,6726,1035,0305,7375,2176,790
EBIT Margin
37.25%40.03%32.16%34.11%35.50%37.52%30.43%32.50%28.62%34.56%27.43%31.29%32.84%35.64%30.04%40.36%33.96%39.34%38.54%45.61%
Effective Tax Rate
12.61%15.47%32.92%31.97%73.67%39.45%22.40%-24.95%36.02%21.82%32.01%8.81%22.34%49.26%16.63%10.18%21.55%8.85%5.29%
SEC Filings: 10-K · 10-Q